26.07.2011 • News

Solutia Q2 Profit Rises

Solutia Monday reported second-quarter net income attributable to the company of $68 million or $0.56 per share, compared to $41 million or $0.34 per share last year.

Adjusted earnings for the quarter increased to $69 million or $0.57 per share, compared to $53 million or $0.44 per share in the prior year period. On average, six analysts polled by Thomson Reuters expected earnings of $0.56 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter grew 8% to $543 million from $502 million in the same period last year. Looking forward, the company maintained its adjusted earnings guidance range of $2.10 to $2.25 for the full year. Analysts currently expect $2.21 per share for the full year.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.